Evidence map›Paper›PMID 32714929›Full record

ReviewFrontiers in cell and developmental biology2020

Functions and Clinical Significance of Super-Enhancers in Bone-Related Diseases.

Jian Qu, Zhanbo Ouyang, Wenqiang Wu, Guohua Li, Jiaojiao Wang, Qiong Lu, Zhihong Li

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in cell and developmental biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jian QuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhanbo OuyangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Wenqiang WuMathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guohua LiDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Jiaojiao WangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Qiong LuDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Zhihong LiHunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CNGuangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Super-enhancers (SEs) are a large cluster of

Indexed as

bone-related diseasesEwing sarcomamultiple myelomaosteosarcomasuper-enhancers

Identifiers

PMID32714929
PMCPMC7344144
OpenAlexW3038229939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.